Elevated levels of a class of hormones called glucocorticoids have long been linked to anxiety disorders and depression. It is known that the presence of too much of these hormones mediates what we call ‘stress’ and that...
You are here
Discoveries ›Next Generation Therapies
Brain & Behavior Research Foundation Scientific Council Member Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for Brain Sciences, is one of the leaders of a multi-center...
NARSAD Distinguished Investigator Grantee, James F. Leckman, M.D., professor of Pediatrics and Psychiatry at the Yale University Child Study Center, is one of the researchers talking part in an ongoing, large-scale study...
Two-time NARSAD Young Investigator Grantee, Olivier Berton, Ph.D., assistant professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania and a team of researchers have shown that the...
The first placebo-controlled trial to verify the effectiveness and safety of deep brain stimulation (DBS) as a treatment for severe, treatment-resistant depression was reported by a team led by NARSAD Grantee Paul E....
Pages
Research by Illness
|
The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research. |
DONATE NOW |










